Dexamethasone – Page 12 – Communicable Diseases Research

Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations

Research article

Published on 2022-05-012022-10-05
Journal: Value in health : the journal of the International [Category] 신약개발, 진단, 치료법,

Efficacy of the combination of baricitinib, remdesivir, and dexamethasone in hypoxic adults with COVID-19: A retrospective study

저산소증 성인 COVID-19에 대한 바리시티닙, 렘데시비르 및 덱사메타손 조합의 효능: 후향적 연구

Article

Published on 2022-05-012022-09-11
Journal: Respiratory medicine and research [Category] COVID19(2023년), SARS, 변종, 치료제,

In silico screening predicts common cold drug Dextromethorphan along with Prednisolone and Dexamethasone can be effective against novel Coronavirus disease (COVID-19)

Article

Published on 2022-05-012022-10-04
Journal: Journal of biomolecular structure & dynamics [Category] COVID19(2023년), SARS, 신약개발,

Acute laryngotracheitis caused by COVID-19: A case report and literature review

Case report

Published on 2022-05-012022-10-05
Journal: International Journal of Surgery Case Reports [Category] 진단,

[키워드] acute respiratory syndrome Adults airway Case report caused Chest radiograph Clinical finding coronavirus Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19coronavirus disease 2019 demonstrated Dexamethasone diagnostic edematous EDemergency department emergency department female HPIVhuman parainfluenza virus human parainfluenza virus ICU ICUIntensive Care Unit infections Infectious disease initiated intensive care intensive care unit intubation laryngotracheitis literature review Nasopharyngeal samples nebulized observation outcome Patient pharyngeal polymerase chain positive presentation regimen SARS-CoV-2 SARS-CoV-2severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 Shortness of breath Symptom tested
[DOI] 10.1016/j.ijscr.2022.107074 [Article Type] Case report

Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia

Article

Published on 2022-05-012022-11-15
Journal: Nefrología [Category] COVID19(2023년), SARS, 치료제,

[키워드] acute kidney failure addition Admission age anticoagulation Antiviral Antiviral treatment chest X-ray clinical criteria Cohort Critical care Deterioration Dexametasona Dexamethasone died Effect English Fracaso renal agudo Hemodialysis hospital discharge Hospitalization IMPROVE kidney kidney transplant Kidney transplantation knowledge less Liver function material men nasal oxygen flow Patient patients treated patients with SARS-CoV-2 performed Placebo Pneumonia pulmonary infiltrate receive Remdesivir renal renal function required retrospective SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 pneumonia shown Side effects Spanish Supervivencia survival the median the patient therapy Trasplante renal Tratamiento Treatment
[DOI] 10.1016/j.nefroe.2022.07.006 PMC 바로가기

COVID-19 and the promise of small molecule therapeutics: Are there lessons to be learnt?

COVID-19와 소분자 치료제의 약속: 배워야 할 교훈이 있습니까?

Review

Published on 2022-05-012022-09-11
Journal: Pharmacological research [Category] COVID19(2023년), SARS, 변종, 신약개발, 치료제,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjuvant therapy Antiviral antiviral agent Antiviral agents antivirals Baricitinib Baricitinib (PubChem CID: 44205240) Chloroquine Chloroquine (PubChem CID: 2719) coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Critical developmental Dexamethasone Dexamethasone (PubChem CID: 5743) drug Drug discovery effective Endemic Healthcare professional healthcare professionals Hydroxychloroquine Hydroxychloroquine (PubChem CID: 3652) Inclusion Ivermectin Ivermectin (PubChem CID: 6321424) limitation Lopinavir Lopinavir (PubChem CID: 92727) molnupiravir Molnupiravir (Pubchem CID: 145996610) Nirmatrelvir Nirmatrelvir (PubChem CID: 155903259) pandemic provided PubChem Remdesivir Remdesivir (PubChem CID: 121304016) researcher Retrospective analysis Ritonavir Ritonavir (PubChem CID: 392622) SARS-CoV-2 severe acute respiratory syndrome Coronavirus small molecule Small molecule therapeutics. standstill tested the disease therapy Treatment treatment of COVID-19 while with COVID-19
[DOI] 10.1016/j.phrs.2022.106201 PMC 바로가기 [Article Type] Review

The Cost-Effectiveness of Remdesivir for Hospitalized Patients With COVID-19

Research article

Published on 2022-05-012022-10-05
Journal: Value in health : the journal of the International [Category] 임상,

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Randomized Controlled Trial

Published on 2022-05-012022-10-05
Journal: Intensive care medicine [Category] Fulltext, MERS, 임상,

Severity-Adjusted Dexamethasone Dosing and Tocilizumab Combination for Severe COVID-19

중증 COVID-19에 대한 중증도 조정 덱사메타손 투여 및 토실리주맙 조합

Article

Published on 2022-05-012022-09-12
Journal: Yonsei medical journal [Category] COVID19(2023년), SARS, 진단,

Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study

Observational Study

Published on 2022-04-192022-10-04
Journal: CMAJ open [Category] COVID19(2023년), SARS, 임상,

[키워드] 28-day mortality 95% CI 95% confidence interval acute COVID-19 adjusted Admission angiotensin receptor blocker ARB association average baseline characteristics changes in cohort study Community Comorbidity conducted COVID-19 pandemic death demographic characteristics Dexamethasone dysfunction examined excluded hospital Hospital admission IMPROVE in-hospital mortality Invasive mechanical ventilation less Logistic lower mortality management Mortality multicentre Observational cohort study Odds ratio organ support outcome outcomes pandemic Patient Pragmatic readmission Regression model remained renal dysfunction renal replacement therapy RRT severity of illness significantly lower therapy Vasopressor with COVID-19
[DOI] 10.9778/cmajo.20210216 PMC 바로가기 [Article Type] Observational Study